Next 10 |
home / stock / nm:cc / nm:cc news
While it is still unknown whether insurance will pay for psychedelics-based mental health treatment, there is some evidence that providers are at least looking for more data on the therapy. Two years ago, the Multidisciplinary Association of Psychedelic Studies (MAPS) worked with Elliot M...
Toronto, Ontario--(Newsfile Corp. - le 13 juin/June 2022) - Novamind Inc. (“Novamind” or the “Company”), has announced that the Company has completed its previously announced acquisition by Numinus Wellness Inc . by way of a plan of arrangemen...
TORONTO, ON / ACCESSWIRE / June 10, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announced today that the Company has completed its previously announced acquisition by Numinus Welln...
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. Numinus shareholders, at a separate meeting held today, have also approved the resolutions related t...
TORONTO, ON / ACCESSWIRE / June 2, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today announced new patient financing options to help patients access critical mental healthcare servic...
Record high quarterly revenue of $3,227,352, +32% over the previous quarter Growth driven by Arizona acquisition, expanding clinic network to eight total locations Numinus to acquire Novamind, creating a preeminent North American platform, spanning 13 wellness clinics, four resear...
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. TORONTO, ON / ACCESSWIRE / May 27, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind"...
Following successful clinical pilot, treatment becomes regular offering at Novamind clinics TORONTO, ON / ACCESSWIRE / May 19, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, toda...
Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. Shareholders are encouraged to vote their common shares prior to the proxy deadline of June 6, 2022 a...
TORONTO, ON / ACCESSWIRE / May 10, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, today announced it has been selected to host a clinical trial for the acute treatment of social anxiet...
News, Short Squeeze, Breakout and More Instantly...
While it is still unknown whether insurance will pay for psychedelics-based mental health treatment, there is some evidence that providers are at least looking for more data on the therapy. Two years ago, the Multidisciplinary Association of Psychedelic Studies (MAPS) worked with Elliot M...
Toronto, Ontario--(Newsfile Corp. - le 13 juin/June 2022) - Novamind Inc. (“Novamind” or the “Company”), has announced that the Company has completed its previously announced acquisition by Numinus Wellness Inc . by way of a plan of arrangemen...
TORONTO, ON / ACCESSWIRE / June 10, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announced today that the Company has completed its previously announced acquisition by Numinus Welln...